Robert B. Belshe
Pharmaceutics
FluGen
United States of America
Biography
Dr. Belshe is the Diana and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology at Saint Louis University. He is an expert in clinical trials design and execution, and his laboratory focuses on antibody responses to viral vaccines, including influenza, RSV and vaccinia. He chaired the NIH/industry cooperative Phase 3 pivotal licensing studies on live attenuated influenza vaccine, he conducted the vaccinia dilution studies for the NIH biodefense initiative and most recently he chaired the NIH and GSK Herpevac Trial for Women.
Research Interest
His research interests include fields likeInfectious Diseases and Immunology
